Becton, Dickinson and Company

Open: 256.55 Close: 256.49 Change: -0.06

Can you guess what an AI found about Becton, Dickinson and Company.

Are looking for the most relevant information about Becton, Dickinson and Company? Investor spend a lot of time searching for information to make investment decisions in Becton, Dickinson and Company. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Becton, Dickinson and Company are: BD, Becton, Dickinson, Company, BDX, declare, quarterly, and the most common words in the summary are: company, dickinson, becton, news, medical, bdx, bd, . One of the sentences in the summary was: BD (Becton, Dickinson and Company) …

Concept Map

Semantic Network

Stock Summary

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines.

Today's Summary

BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 20 23.

Today's News

BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets. BD to Sell Surgical Instrumentation Platform to STERIS. BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 20 23. The Board of Directors of BD has declared the quarterly dividend. BD named to Bloomberg Gender-Equality Index for 4th Consecutive year. BD (Becton, Dickinson and Company) (NYSE: BDX) announced results for its first quarter of fiscal 2023, which ended December 31, 2022. Becton, Dickinson and Company (BDX) has declared a quarterly dividend of $91 per share on J.91 common share on April 25, 2018.

Stock Profile

"Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey."

Keywords

This document will help you to evaluate Becton, Dickinson and Company without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Becton, Dickinson and Company are: BD, Becton, Dickinson, Company, BDX, declare, quarterly, and the most common words in the summary are: company, dickinson, becton, news, medical, bdx, bd, . One of the sentences in the summary was: BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 20 23.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #company #dickinson #becton #news #medical #bdx #bd.